Citigroup
SQZ

Citigroup’s SQZ Biotechnologies Company SQZ Stock Holding History

Citigroup’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16
Closed -$12 – 5992
2022
Q4 		$12 Hold
16
– – ﹤0.01% 5710
2022
Q3 		$0 Sell
16
-548
-97% -$1.64K ﹤0.01% 6530
2022
Q2 		$2K Sell
564
-1,020
-64% -$3.67K ﹤0.01% 5952
2022
Q1 		$8K Sell
1,584
-4,232
-73% -$26.9K ﹤0.01% 5653
2021
Q4 		$52K Buy
5,816
+3,221
+124% +$39.5K ﹤0.01% 5048
2021
Q3 		$37K Buy
2,595
+1,512
+140% +$20.5K ﹤0.01% 4907
2021
Q2 		$16K Buy
1,083
+732
+209% +$9.56K ﹤0.01% 5445
2021
Q1 		$5K Sell
351
-469
-57% -$9.53K ﹤0.01% 5922
2020
Q4 		$24K Buy
+820
New +$20.9K ﹤0.01% 6542

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup's SQZ Position: Q1 2023 in Review

Citigroup sold out of SQZ Biotechnologies Company (SQZ) in Q1 2023, closing a stake of 16 shares — an estimated $12 sold.

Citigroup first reported a position in SQZ in Q4 2020 and held it in 9 quarters. The position peaked at $52K in Q4 2021. 32 funds tracked by Wall St. Rank hold SQZ as of Q1 2023.

  • Citigroup reported no remaining SQZ Biotechnologies Company position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 16 SQZ Biotechnologies Company shares in Q1 2023, an estimated $12.
  • Citigroup first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 9 quarters.
  • Citigroup's SQZ Biotechnologies Company position peaked at $52K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.